A general strategy for the practical synthesis of nojirimycin C-glycosides and analogues. Extension to the first reported example of an iminosugar 1-phosphonate

Journal of Organic Chemistry

Volumn 67, Issue 20, 2002, Pages 6960-6970

  Godin, Guillaume ^a   Compain, Philippe ^a   Masson, Géraldine ^a   Martin, Olivier R ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSIDIC FUNCTIONS;

ADDITION REACTIONS; AMINATION; ORGANOMETALLICS; STEREOCHEMISTRY;

SYNTHESIS (CHEMICAL);

1 DEOXYNOJIRIMYCIN DERIVATIVE; GLYCOSIDE; IMINOSUGAR 1 PHOSPHONATE; LEWIS ACID; NOJIRIMYCIN C GLYCOSIDE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; GLUCOSAMINE; GLYCOSIDES; IMINES; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; STEREOISOMERISM;

EID: 0037019953     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0203903     Document Type: Article

References (87)

1. (a) Inouye, S. E.; Tsuruoka, T.; Ito, T.; Niida, T. Tetrahedron 1968, 24, 2125.
2. (b) Hughes, A. B.; Rudge, A. J. Nat. Prod. Rep. 1994, 135.
3. Stütz, A. E., Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond; Wiley-VCH: Weinheim, 1999.
4. (a) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1645.
5. (b) Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Phytochemistry 2001, 56, 265.
6. Frankowski, A.; Streith, J. C. R. Acad. Sci., Ser. IIc: Chim. 1998, 1, 681.
7. (a) For a recent review on carbohydrate mimetic-based glycosyltransferase inhibitors, see: Compain, P.; Martin, O. R. Bioorg. Med. Chem. 2001, 9, 3077.
8. (b) Schuster, M.; Blechert, S. Bioorg. Med. Chem. Lett. 2001, 11, 1809.
9. (c) Bastida, A.; Fernandez-Mayoralas, A.; Arrayas, R. G.; Iradier, F.; Carretero, J. C.; Garcia-Junceda, E. Chem. Eur. J. 2001, 7, 2390.
10. (a) Fedorov, A.; Shi, W.; Kicska, G.; Fedorov, E.; Tyler, P. C.; Furneaux, R. H.; Hanson, J. C.; Gainsford, G. J.; Larese, J. Z.; Schramm, V. L.; Almo, S. C. Biochemistry 2001, 40, 853.
11. (b) Miles, R. W.; Tyler, P. C.; Furneaux, R. H.; Bagdassarian, C. K.; Schramm, V. L. Biochemistry 1998, 37, 8615.
12. (c) Kline, P. C.; Schramm, V. L. Biochemistry 1993, 32, 13212.
13. Jakobsen, P.; Lundbeck, J. M.; Kristiansen, M.; Breinholt, J.; Demuth, H.; Pawlas, J.; Candela, M. P. T.; Andersen, B.; Westergaard, N.; Lundgren, K.; Asano, N. Bioorg. Med. Chem. 2001, 9, 733.
14. (a) Lee, R. E.; Smith, M. D.; Pickering, L.; Fleet, G. W. J. Tetrahedron Lett. 1999, 40, 8689.
15. (b) Lee, R. E.; Smith, M. D.; Nash, R. J.; Griffiths, R. C.; McNeil, M.; Grewal, R. K.; Yan, W.; Besra, G. S.; Brennan, P. J.; Fleet, G. W. J. Tetrahedron Lett. 1997, 38, 6733.
16. Alper, J. Science 2001, 291, 2338.
17. (a) Dimitriadis, G. D.; Tessari, P.; Go, V. L. W.; Gerich, J. E. Metabolism 1985, 34, 261.
18. (b) Bollen, M.; Stalmans, W. Eur. J. Biochem. 1989, 181, 775.
19. (c) Andersen, B.; Rassov, A.; Westergaard, N.; Lundgren, K. Biochem. J. 1999, 342, 545.
20. (a) Häusler, H.; Kawakami, P.; Mlaker, E.; Severn, W. B.; Wrodnigg, T. M.; Stütz, A. E. J. Carbohydr. Chem. 2000, 19, 435.
21. (b) Durantel, D.; Branza-Nichita, N.; Carrouee-Durantel, S.; Butters, T. D.; Dwek, R. A.; Zitzmann, N. J. Virol. 2001, 75, 8987.
22. (a) Goss, P. E.; Baker, M. A.; Carver, J. P.; Dennis, J. W. Clin. Cancer Res. 1995, 1, 935.
23. (b) Humphries, M. J.; Matsumoto, K.; White, S. L.; Olden, K. Cancer Res. 1986, 46, 5215.
24. (c) Nishimura, Y.; Satoh, T.; Adachi, H.; Kondo, S.; Takeuchi, T.; Azetaka, M.; Fukuyasu, H.; Lizuka, Y. J. Med. Chem. 1997, 40, 2626.
25. Butters, T. D.; Dwek, A.; Platt, F. M. Chem Rev. 2000, 100, 4683.
26. Butters, T. D.; van den Broek, L. A. G. M.; Fleet, G. W. J.; Krulle, T. M.; Wormald, M. R.; Dwek, R. A.; Platt, F. M. Tetrahedron: Asymmetry 2000, 11, 113.
27. For a chemical chaperone therapy of another lysosomal storage disorder (Fabry disease) using iminosugars, see: (a) Fan, J.-Q.; Ishii, S.; Asano, N.; Suzuki, Y. Nature Med. 1999, 5, 112. (b) Asano, N.; Ishii, S.; Kizu, H.; Ikeda, K.; Yasuda, K.; Kato, A.; Martin, O. R.; Fan, J. Q. Eur. J. Biochem. 2000, 267, 4179.
28. For a chemical chaperone therapy of another lysosomal storage disorder (Fabry disease) using iminosugars, see: (a) Fan, J.-Q.; Ishii, S.; Asano, N.; Suzuki, Y. Nature Med. 1999, 5, 112. (b) Asano, N.; Ishii, S.; Kizu, H.; Ikeda, K.; Yasuda, K.; Kato, A.; Martin, O. R.; Fan, J. Q. Eur. J. Biochem. 2000, 267, 4179.
29. Cox, T.; Lachmann, R.; Hollak, C.; Aerts, J.; van Weely, S.; Hrebicek, M.; Platt, F.; Butters, T.; Dwek, R.; Moyses, C.; Gow, I.; Elstein, D.; Zimran, A. Lancet 2000, 355, 1481.
30. Liu, P. S. J. Org. Chem. 1987, 52, 4717.
31. Kite, G. C.; Fellows, L. E.; Fleet, G. W. J.; Liu, P. S.; Scofield, A. M.; Smith, N. G. Tetrahedron Lett. 1988, 29, 6483.
32. (a) Heightman, T. D.; Vasella, A. T. Angew. Chem., Int. Ed. 1999, 38, 750.
33. (b) Withers, S. G.; Namchuk, M.; Mosi, R. In Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond; Stütz, A. E., Ed.; Wiley-VCH: Weinheim, 1999; pp 188-206.
34. (c) Davies, G.; Sinnott, M. L.; Withers, S. G. Glycosyl transfer. In Comprehensive Biological Catalysis; Sinnott, M. L., Ed.; Academic Press Limited: New York, 1997; Chapter 3, pp 119-208.
35. Johns, B. A.; Pan, Y. T.; Elbein, A. D.; Johnson, C. R. J. Am. Chem. Soc. 1997, 119, 4856.
36. Fuchss, T.; Schmidt, R. R. Synthesis 2000, 259.
37. (a) Liotta, L. J.; Lee, J.; Ganem, B. Tetrahedron 1991, 47, 2433.
38. (b) Johnson, C. R.; Golebiowski, A.; Sundram, H.; Miller, M. W.; Dwaihy, R. L. Tetrahedron Lett. 1995, 36, 653.
39. (c) Johns, B. A.; Johnson, C. R. Tetrahedron Lett. 1998, 39, 749.
40. (d) Fuchss, T.; Streicher, H.; Schmidt, R. R. Liebigs Ann. / Recueil 1997, 1315.
41. (e) Zhu, Y.-H.; Vogel, P. J. Org. Chem. 1999, 64, 666.
42. (f) Cipolla, L.; Lay, L.; Nicotra, F.; Pangrazio, C.; Panza, L. Tetrahedron 1995, 51, 4679.
43. (g) Cipolla, L.; La Ferla, B.; Peri, F.; Nicotra, F. Chem. Commun. 2000, 1289.
44. (h) Duff, F. J.; Vivien, V.; Wightman, R. H. Chem. Commun. 2000, 2127.
45. (i) Cheng, X.; Kumaran, G.; Mootoo, D. R. Chem. Commun. 2001, 811.
46. (j) Dransfield, P. J.; Gore, P. M.; Shipman, M.; Slawin, M. Z. Chem. Commun. 2002, 150.
47. (a) Martin, O. R. In Carbohydrate Mimics: Concepts and Methods; Chapleur, Y., Ed.; Wiley-VCH: New York, 1997; p 259-282.
48. (b) Martin, O. R.; Compain, P.; Kizu, H.; Asano, N. Bioorg. Med. Chem. Lett. 1999, 9, 3171.
49. (c) Tezuka, K.; Compain, P.; Martin, O. R. Synlett 2000, 1837.
50. (d) Rambaud, L.; Compain, P.; Martin, O. R. Tetrahedron: Asymmetry 2001, 12, 1807.
51. (e) Martin, O. R.; Saavedra, O. M.; Xie, F.; Liu, L.; Picasso, S.; Vogel, P.; Kizu, H.; Asano, N. Bioorg. Med. Chem. 2001, 9, 1269.
52. Masson, G.; Compain, P.; Martin, O. R. Org. Lett. 2000, 2, 2971.
53. It is noteworthy that L-sorbose has been used as the starting material for the first synthesis, as well as for some of the shortest syntheses, of 1-deoxynojirimycin, but not for the preparation of chain-extended analogues (see ref 1b).
54. (a) Look, G. C.; Fotsch, C. H.; Wong, C.-H. Acc. Chem. Res. 1993, 26, 182.
55. (b) Saavedra, O. M.; Martin, O. R. J. Org. Chem. 1996, 61, 6987.
56. In our hands, compound 6 could be obtained in one step from L-sorbose in 80% yield; see: Paulsen, H.; Sangster, I.; Heyns, K. Chem. Ber. 1967, 100, 802.
57. Izquierdo, I.; Plaza, M. T.; Kari, N. Carbohydr. Res. 1995, 268, 187.
58. Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
59. Feldman, K. S.; Mingo, P. A.; Hawkins, P. C. D. Heterocycles 1999, 51, 1283.
60. Bloch, R. Chem. Rev. 1998, 98, 1407.
61. (a) Inch, T. D. Adv. Carbohydr. Chem. 1972, 27, 191.
62. (b) Danishefsky, S. J.; DeNinno, M. P.; Phillips, G. B.; Zelle, R. E.; Lartey, P. A. Tetrahedron 1986, 42, 2809.
63. van Delft, F. L.; de Kort, M.; van der Marel, G. A.; van Boom, J. H. J. Org. Chem. 1996, 61, 1883.
64. For related examples, see: (a) Akhoon, K. M.; Myles, D. C. J. Org. Chem. 1997, 62, 6041.
65. (b) Veith, U.; Schwardt, O.; Jäger, V. Synlett 1996, 1181.
66. (c) Compain, P.; Goré, J.; Vatèle, J.-M. Tetrahedron Lett. 1995, 36, 4059.
67. Heyns, K.; Heukeshoven, J. Justus Liebig Ann. Chem. 1976, 269.
68. Nortey, S. O.; Wu, W.-N.; Maryanoff, B. E. Carbohydr. Res. 1997, 304, 29.
69. Diol 16c with the vinyl group at C1 was found to decompose after a few days of storage at -20°C. To avoid this degradation, 16c was directly acetylated after the reductive amination reaction.
70. Böshagen, H.; Geiger, W.; Junge, B. Angew. Chem., Int. Ed. Engl. 1981, 20, 806.
71. Baxter, E. W.; Reitz, A. B. J. Org. Chem. 1994, 59, 3175.
72. Hers, H. G. Biochem. Soc. Trans. 1984, 12, 729.
73. Macdonald, D. L. In The Carbohydrates: Chemistry and Biochemistry; Pigman, W., Horton, D., Eds.; Academic Press: New York, 1972; Vol. 1A, pp 253-277.
74. Nicotra, F. In Carbohydrate Mimics: Concepts and Methods; Chapleur, Y., Ed.; Wiley-VCH: New York, 1997; pp 67-85.
75. (a) Vasella, A.; Baudin, G.; Panza, L. Heteroatom Chem. 1991, 2, 151 and references therein.
76. (b) Vaghefi, M. M.; Bernacki, R. J.; Dalley, N. K.; Wilson, B. E.; Robins, R. K. J. Med. Chem. 1987, 30, 1383.
77. (c) Chmielewski, M.; BeMiller, J. N.; Cerretti, D. P. Carbohydr. Res. 1981, 97, C1.
78. (d) Meuwly, R.; Vasella, A. Helv. Chim. Acta 1986, 69, 25.
79. For examples of iminosugar C-glycoside analogues of glycosyl 1-phosphate, see: (a) Reference 5b. (b) Bosco, M.; Bisseret, P.; Bouix-Peter, C.; Eustache, J. Tetrahedron Lett. 2001, 42, 7949. (c) Schuster, M.; He, W.-F.; Blechert, S. Tetrahedron Lett. 2001, 42, 2289. (d) Gautier-Lefebvre, I.; Behr, J.-B.; Guillerm, G.; Ryder, N. S. Bioorg. Med. Chem. Lett. 2000, 10, 1483. (e) Kajimoto, T.; Chen, L.; Liu, K. K.-C.; Wong, C.-H. J. Am. Chem. Soc. 1991, 113, 6678.
80. For examples of iminosugar C-glycoside analogues of glycosyl 1-phosphate, see: (a) Reference 5b. (b) Bosco, M.; Bisseret, P.; Bouix-Peter, C.; Eustache, J. Tetrahedron Lett. 2001, 42, 7949. (c) Schuster, M.; He, W.-F.; Blechert, S. Tetrahedron Lett. 2001, 42, 2289. (d) Gautier-Lefebvre, I.; Behr, J.-B.; Guillerm, G.; Ryder, N. S. Bioorg. Med. Chem. Lett. 2000, 10, 1483. (e) Kajimoto, T.; Chen, L.; Liu, K. K.-C.; Wong, C.-H. J. Am. Chem. Soc. 1991, 113, 6678.
81. For examples of iminosugar C-glycoside analogues of glycosyl 1-phosphate, see: (a) Reference 5b. (b) Bosco, M.; Bisseret, P.; Bouix-Peter, C.; Eustache, J. Tetrahedron Lett. 2001, 42, 7949. (c) Schuster, M.; He, W.-F.; Blechert, S. Tetrahedron Lett. 2001, 42, 2289. (d) Gautier-Lefebvre, I.; Behr, J.-B.; Guillerm, G.; Ryder, N. S. Bioorg. Med. Chem. Lett. 2000, 10, 1483. (e) Kajimoto, T.; Chen, L.; Liu, K. K.-C.; Wong, C.-H. J. Am. Chem. Soc. 1991, 113, 6678.
82. For examples of iminosugar C-glycoside analogues of glycosyl 1-phosphate, see: (a) Reference 5b. (b) Bosco, M.; Bisseret, P.; Bouix-Peter, C.; Eustache, J. Tetrahedron Lett. 2001, 42, 7949. (c) Schuster, M.; He, W.-F.; Blechert, S. Tetrahedron Lett. 2001, 42, 2289. (d) Gautier-Lefebvre, I.; Behr, J.-B.; Guillerm, G.; Ryder, N. S. Bioorg. Med. Chem. Lett. 2000, 10, 1483. (e) Kajimoto, T.; Chen, L.; Liu, K. K.-C.; Wong, C.-H. J. Am. Chem. Soc. 1991, 113, 6678.
83. For examples of iminosugar C-glycoside analogues of glycosyl 1-phosphate, see: (a) Reference 5b. (b) Bosco, M.; Bisseret, P.; Bouix-Peter, C.; Eustache, J. Tetrahedron Lett. 2001, 42, 7949. (c) Schuster, M.; He, W.-F.; Blechert, S. Tetrahedron Lett. 2001, 42, 2289. (d) Gautier-Lefebvre, I.; Behr, J.-B.; Guillerm, G.; Ryder, N. S. Bioorg. Med. Chem. Lett. 2000, 10, 1483. (e) Kajimoto, T.; Chen, L.; Liu, K. K.-C.; Wong, C.-H. J. Am. Chem. Soc. 1991, 113, 6678.
84. Briner, K.; Vasella, A. Helv. Chim. Acta 1987, 70, 1341.
85. Afarinkia, K.; Rees, C. W.; Cadogan, J. I. G. Tetrahedron 1990, 46, 7175.
86. Yadav, J. S.; Reddy, B. V. S.; Sarita Raj, K.; Bhaskar Reddy, K.; Prasad, A. R. Synthesis 2001, 2277.
87. Very recently, Schmidt et al. observed that the presence of UDP on the β-side of the sugar donor moiety of a bisubstrate analogue led to higher inhibition of a retaining glycosyltransferase (galactosyltransferase LgtC from Neisseria meningitidis) than when UDP was on the α-side as in the natural sugar nucleotide donor: Waldscheck, B.; Streiff, M.; Notz, W.; Kinzy, W.; Schmidt, R. R. Angew. Chem., Int. Ed. 2001, 40, 4007.